Meet the team
No Patient Left Behind was founded in 2020 by a group of patients, patient advocates, physicians, scientists, policymakers, industry leaders, and biotech investors.
NPLB team members
Priscilla VanderVeer
EXECUTIVE DIRECTOR
No Patient Left Behind
Jevan Jammal
VP of Development
No Patient Left Behind
Ben Cohen
SENIOR DIRECTOR OF HEALTH ECONOMICS
No Patient Left Behind
Halley Ray
DIRECTOR OF OPERATIONS
No Patient Left Behind
Elena Solopova
DIRECTOR OF EDUCATION
No Patient Left Behind
Co-chairs, Advisory Board
Keith Murphy
CO-CHAIR, ADVISORY BOARD
CEO and Founder, Viscient Biosciences
Sara Nayeem
CO-CHAIR, ADVISORY BOARD
EVP, Investments, Enavate Sciences
Board and steering committee members
Alice Valder Curran
STEERING COMMITTEE
Life Sciences Regulatory Expert and Partner, Hogan Lovells
Gunnar Esiason
BOARD MEMBER
Director of Patient Outreach, Boomer Esiason Foundation
Jim Greenwood
STEERING COMMITTEE
Former President and CEO, Biotechnology Industry Organization
DA Wallach
BOARD MEMBER
Venture Capital Investor and Recording Artist
Heidi Wagner
BOARD MEMBER
Patricia Fraser
BOARD MEMBER
Safety Physician, Sanofi Genzyme, Rheumatologist, Brigham and Women’s
David Beier
BOARD MEMBER
Globally recognized leader in healthcare policy and pricing
Jessica Sagers
BOARD MEMBER
Peter Kolchinsky
STEERING COMMITTEE
Founder of NPLB. Founder and Managing Director, RA Capital Management
Peter Rubin
BOARD MEMBER
Former Executive Director, No Patient Left Behind
Lindsay Androski
BOARD MEMBER
President, CEO & Chairman, Arbutus Bio
Tamar Thompson
BOARD MEMBER
VP, Head of Patient Experience & Insights, Alexion Pharmaceuticals/AstraZeneca Rare Disease
Special advisors
Richard Xie
Senior Economic and Policy Advisor
Health economics and value assessment
We’re building support across the biotech ecosystem
BECOME A FIRST RESPONDER & THOUGHT PARTNER
Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.